BTTC11-01: Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas
Cancer - Brain
- Patients must be 18 years or older.
- Patients with histologically confirmed supratentorial high-grade glioma will be eligible for this protocol.
- All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.
Please contact us for full eligibility criteria.